Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

‘Zombie’ gene may protect elephants from cancer
Elephants possess an anti-cancer gene that can return from the dead.
Gene returns to life and kills cells with damaged DNA

A ‘zombie’ gene inherent in elephants may help to protect them against cancer, according to new research.

Humans and animals have one copy of the master suppressor gene, p53. The gene allows the body to recognise un-repaired DNA damage, a precursor of cancer, and causes those damaged cells to die.

But researchers at the Universities of Chicago and Utah recently found that elephants have 20 copies of p53. This makes their cells far more sensitive to damaged DNA and therefore quicker to die.

Now, new research reported in the journal Cell Reports details the second element of this process: an anti-cancer gene that can return from the dead.

“Genes duplicate all the time,” said Vincent Lynch, assistant professor of human genetics at the University of Chicago and the study’s senior author. “Sometimes they make mistakes, producing non-functional versions known as pseudogenes. We often refer to these dismissively as dead genes.”

While studying p53 in elephants, Lynch and his team discovered a former pseudogene - leukaemia inhibitory factor 6 (LIF6) - that had, by some means, evolved a new on-switch.

LIF6, which had returned from the dead, had become a valuable working gene. When activated by p53, its function is to respond to damaged DNA by killing the cell.

The LIF6 gene makes a protein that goes to the mitochondria, the cell’s main energy source. That protein pokes holes in the mitochondria, causing the cell to die.

“Hence, zombie,” said Lynch. “This dead gene came back to life. When it gets turned on by damaged DNA, it kills that cell, quickly. This is beneficial because it acts in response to genetic mistakes, errors made when the DNA is being repaired. Getting rid of that cell can prevent subsequent cancer.”

The researchers note that exactly how LIF6 triggers apoptosis remains unclear and will be the focus of future studies.

Become a member or log in to add this story to your CPD history

RCVS announces 1CPD app update

News Story 1
 The RCVS has announced a new version of its 1CPD mobile app, with enhanced features for veterinary surgeons and veterinary nurses to record their continuing professional development.

The mobile app includes a new 'what would you like to do?' shortcut for frequent tasks, a notification badge, and the ability to scan a QR code from the home screen to easily record an activity.

Users will be prompted to update the app from the App Store or Google Play the next time they log in. For more information, visit RCVS.org.uk 

Click here for more...
News Shorts
Nominations open for RCVS and VN Council elections

The nomination period for the 2026 RCVS Council and VN Council elections is now open, with three veterinary surgeon seats and two veterinary nurse seats available.

Prospective candidates can download an information pack and nomination form from the RCVS website. Individuals can nominate themselves for the elections, with the results to be announced in the spring.

Clare Paget, the recently appointed RCVS Registrar and elections returning officer, said: "If you want to play your part in influencing and moulding how the professions are regulated, and making key decisions on matters of great importance to your peers, the public and animal health and welfare, please consider standing for RCVS Council or VN Council next year."

Nominations close at 5pm on Saturday, 31 January 2026.